Ultrasound-Guided Margin Selection for Crohn's Disease
(SMILE-CD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help surgeons determine where to cut during surgery for individuals with Crohn's disease in the last part of their small intestine. It compares an ultrasound technique, specifically IOUS-guided margin selection, with the usual method of using sight and touch to find the optimal cutting location. The goal is to determine if the ultrasound method improves outcomes after surgery. Individuals with Crohn's disease affecting their terminal ileum who are scheduled for surgery might be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative surgical techniques that could enhance future patient care.
What prior data suggests that IOUS-guided margin selection is safe for Crohn's disease surgery?
Research has shown that intraoperative ultrasound (IOUS) during surgery for Crohn's disease is under study for its safety and effectiveness. One study found that IOUS led to more precise surgical results, with fewer instances of leftover diseased tissue. Importantly, side effects did not significantly differ from those of traditional methods. This suggests that IOUS is a safe tool for Crohn’s disease surgery. The technique involves assessing the thickness and structure of the bowel wall to ensure accurate removal of affected areas, showing promise in improving surgical outcomes without adding extra risk to patients.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new technique, ultrasound-guided margin selection, for Crohn's disease surgeries. Unlike the standard method where surgeons rely on sight and touch to determine where to cut, this approach uses intraoperative ultrasound (IOUS) to pinpoint the best spot for resection. By focusing on criteria like the thickness of the bowel wall and its layer structure, this technique aims to reduce complications and improve healing. If successful, it could mean more precise surgeries and better outcomes for patients with Crohn's disease.
What evidence suggests that IOUS-guided margin selection is effective for Crohn's disease?
Research has shown that using intraoperative ultrasound (IOUS) during surgery can guide surgeons in Crohn's disease operations. In this trial, one group of participants will undergo IOUS-guided margin selection, labeled as "Margin B." Studies have shown that this method results in a much lower chance of leaving behind disease tissue compared to traditional surgery methods (18.5% vs. 48.1%). IOUS helps surgeons remove affected areas more accurately. Another group will have macroscopic margin selection, labeled as "Margin A," which represents the current standard of care. Ultrasound can also detect disease not visible to the naked eye. This technique has been shown to predict healing and remission in Crohn's disease, making it a promising tool for surgery.12567
Are You a Good Fit for This Trial?
This trial is for people with Crohn's disease who need surgery to remove the end of their small intestine (ileocecal resection).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo ileocecal resection with either IOUS-guided or standard margin selection
Follow-up
Participants are monitored for histologic inflammation and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- IOUS-guided margin selection
Trial Overview
The study compares two ways surgeons decide how much tissue to remove: one uses ultrasound during surgery (IOUS-guided), and the other relies on what can be seen by eye. Patients are randomly assigned to either group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
After the surgeon initially selects the macroscopic Margin A, IOUS will be performed to guide the selection of a proximal resection margin ("Margin B"). Margin B will be defined by specific IOUS criteria: mural thickness ≤ 2.5 mm and preserved stratification of the bowel wall.
The proximal transection site of the ileocecal resection will be chosen by the surgeon based on gross visual and tactile assessment of the bowel ("Margin A"). This represents the current standard of care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Citations
Ultrasound-Guided Surgical Margins for Terminal Ileal Crohn's ...
This single-center randomized study is investigating whether intra-operative ultrasound can feasibly guide the proximal resection margin in ...
2.
gastroenterologyandhepatology.net
gastroenterologyandhepatology.net/archives/august-2023/current-and-novel-uses-of-intestinal-ultrasound-in-inflammatory-bowel-disease/Current and Novel Uses of Intestinal Ultrasound in ...
IUS response was observed as early as week 4, improving over time through week 48. CEUS showed 93.5% sensitivity, 93.7% specificity, and 93.6% overall accuracy ...
Use of Intraoperative Ultrasonography of the Small Bowel to ...
The IOUS group presented a lower rate of histological positive margins (18.5% vs. 48.1%; p = 0.021). No significant differences were found in terms of mean ...
Rethinking Intra-operative Management of Crohn's Disease
The IOUS group presented a lower rate of histological positive margins (18.5% vs. 48.1%; p = 0.021). No significant differences were found in ...
Intestinal Ultrasound Predicts Endoscopic Remission in ...
Intestinal ultrasound (IUS) remission at 54 weeks was achieved by 42% of patients compared to 40% for endoscopic remission.
Intraoperative Ultrasound in Crohn's Disease
The outcome of intraoperative ultrasound will be schematized as positive or negative based on the presence or absence of specific ultrasound signs of intestinal ...
Intraoperative Ultrasound in Colorectal Surgery
Crohn's disease. The IOUS revealed the tumor and its margin in rectal lesions, making the sphincter-sparing operation easier to perform.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.